In 2024, pivotal advancements in gastrointestinal cancer research have emerged, spotlighting innovative treatments and potential new standards of care. Highlights include the promising efficacy of sotorasib plus panitumumab for KRAS-mutant metastatic colorectal cancer, and the success of novel combinations like durvalumab with bevacizumab and TACE for hepatocellular carcinoma.
Top Gastrointestinal Cancer Research of 2024 (Gastroenterology Advisor)
0